Skip to main content

Featured

New Grocery Benefit Coming in 2027: How Much Could Canadians Receive and Who Qualifies?

  New Grocery Benefit Coming in 2027: How Much Could Canadians Receive and Who Qualifies? November 20, 2026 With grocery bills, housing costs and everyday expenses continuing to put pressure on Canadian households, the federal government has announced another round of financial assistance aimed at helping Canadians make ends meet. On November 16, 2026, the federal government announced a proposed one-time payment through the 2027 Canada Groceries and Essentials Benefit Supplement . The payment is expected to reach more than 12 million low- and modest-income Canadians in early 2027. For eligible Canadians, this could mean hundreds of additional dollars to help cover groceries, household necessities and other everyday expenses. But how much could you receive? Who qualifies? And what do you need to do to make sure you don't miss out? Here's what Canadians should know. 1. What Is the New 2027 Grocery Benefit? The proposed 2027 Canada Groceries and Essentials Benefit Supplement is pa...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments